Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021.
- DOI
- 10.3390/biomedicines10092325
- Published
- 2022 Sep 19
- Container
- Biomedicines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines10092325,
title = {Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021.},
author = {Martins AC and Oshiro MY and Albericio F and de la Torre BG and Pereira GJV and Gonzaga RV},
year = {2022},
journal = {Biomedicines},
doi = {10.3390/biomedicines10092325},
url = {https://doi.org/10.3390/biomedicines10092325}
}RIS
TY - JOUR TI - Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021. AU - Martins AC AU - Oshiro MY AU - Albericio F AU - de la Torre BG AU - Pereira GJV AU - Gonzaga RV PY - 2022 JO - Biomedicines DO - 10.3390/biomedicines10092325 UR - https://doi.org/10.3390/biomedicines10092325 ER -
APA
AC, M., MY, O., F, A., BG, D. L. T., GJV, P., & RV, G. (2022). Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021.. Biomedicines. https://doi.org/10.3390/biomedicines10092325
Source records
- pubmed · retrieved 2026-09-27T14:36:36.560Z